The efficacy of inhibiting tumour necrosis factor and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons

New treatments that inhibit the cytokines tumour necrosis factor alpha (TNFalpha) and interleukin 1 (IL-1) in the treatment of rheumatoid arthritis have proven clinical effect against placebo and methotrexate (MTX) in several clinical trials in early and late-stage disease and different severity gro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Richard M. Nixon, Nick Bansback, Alan Brennan
Formato: Revisão
Idioma:inglés
Publicado: 2007
Acceso en liña:https://doi.org/10.1093/rheumatology/kem072
https://academic.oup.com/rheumatology/article-pdf/46/7/1140/9449311/kem072.pdf
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!